查看購物車
  • Simplified Chinese
  • English
  • Japanese
核醫設備市場-全球及區域分析：依應用、最終用戶及區域-分析與預測（2025-2035年）
市場調查報告書
商品編碼
1808108

核醫設備市場-全球及區域分析：依應用、最終用戶及區域-分析與預測（2025-2035年）

Nuclear Medicine Equipment Market - A Global and Regional Analysis: Focus on Application, End User, Country, and Region - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 100 Pages | 商品交期: 1-5個工作天內

價格

全球核子醫學設備市場 - 分析與預測（2025-2035）

核子醫學設備是使用放射性物質來診斷、治療和管理各種疾病的專用醫療設備。

這些儀器旨在使體內過程可視化，使醫療專業人員能夠檢測腫瘤、心臟病、神經系統疾病等異常情況。核子醫學設備通常包括正子斷層掃描 (PET)、單光子發射電腦斷層掃描 (SPECT) 等影像系統，以及 PET/CT 和 SPECT/CT 等混合系統。

這些設備使用放射性同位素或放射性藥物，以注射、吸入或口服的方式給藥。這些放射性同位素發射的輻射被成像系統拾取，從而產生內部結構和功能的詳細圖像。核子醫學通常用於評估心臟、大腦和骨骼等器官的功能，並在癌症的檢測和分期、心血管健康狀況評估以及治療效果監測方面發揮重要作用。

除了診斷成像外，核醫學系統還用於治療目的，例如靶向放射線治療，它透過將放射性同位素直接輸送到癌細胞來治療癌症。技術的不斷進步，例如整合人工智慧以實現更好的影像解釋以及開發更有效率、更方便患者的系統，正在提高核醫學系統的能力和可訪問性。

核醫設備市場的主要驅動力之一是慢性疾病（尤其是癌症、心血管疾病和神經系統疾病）盛行率的上升。隨著這些疾病在全球範圍內持續上升，對能夠實現早期發現、準確診斷和有效治療監測的先進診斷工具的需求也日益成長。核子醫學在提供精準的非侵入性影像解決方案方面發揮關鍵作用，這些解決方案能夠在分子層面上實現疾病可視化，幫助醫療保健提供者及早發現疾病並制定個人化治療方案。利用PET/CT和SPECT/CT掃描儀等核醫技術檢測和監測複雜疾病的能力，使這些工具在現代醫療保健中發揮著不可估量的作用，從而推動市場成長。

儘管核醫設備市場正在成長，但仍存在一些挑戰。其中最主要的挑戰之一是設備成本高。 PET/CT 和 SPECT/CT 掃描儀等核醫設備需要大量投資，這對許多醫療機構，尤其是發展中地區或小型醫療中心的醫療機構來說可能是一個障礙。

初始購買、維護、安裝和營運成本對於許多醫療保健組織來說過高，限制了它們獲得先進診斷工具的機會並降低了採用高成本，尤其是在醫療保健預算有限和報銷系統薄弱的地區。

因此，我們持續需要更具成本效益的解決方案和財務模型，以使更廣泛的醫療保健提供者能夠使用核子醫學技術。

全球核醫設備市場競爭激烈，領先公司包括西門子醫療、通用電氣醫療、荷蘭皇家飛利浦、佳能醫療系統、Mediso 醫學影像系統、Digirad Corporation、SurgicEye GmbH、DDD-Diagnostic A/S 和東軟醫療系統有限公司。這些公司處於技術創新的前沿，不斷開發新技術並改進現有產品，以滿足對先進核醫學解決方案日益成長的需求。

西門子醫療和通用電氣醫療憑藉其廣泛的診斷影像系統產品組合佔據市場主導地位，其中包括混合PET/CT和SPECT/CT掃描儀，這些掃描儀對於精確的診斷影像至關重要。飛利浦醫療和佳能醫療系統也憑藉其提供更高解析度和診斷準確性的高品質診斷影像設備做出了巨大貢獻。 Mediso和Digirad等規模較小的公司專注於利基市場，提供固體伽馬攝影機和緊湊型成像系統等專業產品，以滿足對功能更豐富、價格更實惠的解決方案日益成長的需求。

這些公司也大力投資研發，將人工智慧、機器學習和改良放射性藥物領域的最新進展融入其產品中。策略夥伴關係、收購和地理擴張對於在這個快速發展的市場中保持競爭力也至關重要。隨著全球醫療保健系統擴大採用核醫學技術進行疾病檢測和治療，這些市場領導將繼續塑造產業的未來。

核子醫學設備市場細分

細分一：依應用

  • 心臟病學
  • 腫瘤學
  • 神經病學
  • 其他

細分 2：依最終用戶

  • 醫院
  • 診斷影像中心
  • 學術研究中心
  • 其他

細分3：依地區

  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

全球核子醫學設備市場最重要的新興趨勢之一是將人工智慧 (AI) 和機器學習 (ML) 融入診斷影像系統。這些技術透過提高診斷準確性、最佳化工作流程並實現個人化治療方案，正在徹底改變該領域。

人工智慧和機器學習演算法正擴大用於分析來自PET/CT和SPECT/ 電腦斷層掃描的複雜影像數據，從而能夠更準確地檢測腫瘤、心血管疾病和神經系統疾病等異常情況。透過自動化影像解讀和量化放射性示蹤劑的攝取，這些技術可以幫助臨床醫生更快、更準確地做出診斷。此外，人工智慧主導的工具透過將影像觀察與患者特定數據關聯起來，促進個人化治療策略的製定，從而實現量身定做的治療方案。

這一趨勢得到了混合成像技術的進步的支持，該技術結合了功能性和解剖性圖像，可以全面洞察疾病過程。由於對更有效率、準確和個人化的醫療保健解決方案的需求，預計核子醫學領域對人工智慧和機器學習的應用將繼續成長。

本報告研究了全球核醫設備市場，並提供了市場概述、應用、最終用戶和地區的趨勢以及參與市場的公司概況。

目錄

執行摘要

第1章全球核子醫學設備市場：產業展望

  • 介紹
  • 市場趨勢
  • 法律規範
  • 專利分析
  • 案例研究
  • 產品基準
  • 市場動態

第 2 章。全球核子醫學設備市場（依應用），2024-2035 年

  • 心臟病學
  • 腫瘤學
  • 神經病學
  • 其他

3. 全球核醫設備市場（依最終用戶分類），2024-2035 年

  • 醫院
  • 診斷影像中心
  • 學術研究中心
  • 其他

4. 2023-2035年全球核醫設備市場（依地區）

  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

第5章全球核子醫學設備市場：競爭格局與公司概況

  • 關鍵策略和發展
  • 公司簡介
    • Koninklijke Philips NV
    • Siemens Healthineers AG
    • GE Healthcare
    • Digirad Corporation
    • Mediso Medical Imaging Systems Ltd.
    • SurgicEye GmbH
    • Canon Medical Systems Corporation
    • DDD-Diagnostic A/S
    • Neusoft Medical Systems Co., Ltd.
    • CMR Naviscan Corporation

第6章調查方法

Product Code: BHM3237SA

Global Nuclear Medicine Equipment Market, Analysis and Forecast: 2025-2035

Nuclear medicine equipment refers to specialized medical devices used for the diagnosis, treatment, and management of various diseases using radioactive substances. These devices are designed to visualize internal bodily processes, allowing healthcare professionals to detect abnormalities such as tumors, heart disease, and neurological conditions. Nuclear medicine equipment typically includes imaging systems like Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), and hybrid systems like PET/CT and SPECT/CT, which combine functional imaging with anatomical information for more precise results.

The equipment works by using radiopharmaceuticals radioactive isotopes that are either injected, inhaled, or ingested by the patient. These substances emit radiation, which is captured by the imaging system to create detailed images of the body's internal structures and functions. Nuclear medicine is often used to assess the functioning of organs like the heart, brain, and bones, and it plays a critical role in detecting and staging cancer, evaluating cardiovascular health, and monitoring treatment response.

In addition to diagnostic imaging, nuclear medicine equipment is also used for therapeutic purposes, such as targeted radiation therapy, where radioactive isotopes are used to treat cancer by delivering radiation directly to tumor cells. The continuous advancements in technology, including the integration of artificial intelligence for better image interpretation and the development of more efficient and patient-friendly systems, are enhancing the capabilities and accessibility of nuclear medicine equipment.

One of the key drivers of the nuclear medicine equipment market is the rising prevalence of chronic diseases, particularly cancer, cardiovascular diseases, and neurological disorders. As these diseases continue to increase globally, there is a growing demand for advanced diagnostic tools that can enable early detection, accurate diagnosis, and effective treatment monitoring. Nuclear medicine plays a critical role in providing precise, non-invasive imaging solutions that allow for the visualization of disease at the molecular level, helping healthcare providers to detect conditions early and tailor personalized treatment plans. The ability to detect and monitor complex diseases using nuclear medicine technologies, such as PET/CT and SPECT/CT scanners, has made these tools invaluable in modern healthcare, driving the market's growth.

Despite the growth of the nuclear medicine equipment market, several challenges persist. One of the primary challenges is the high cost of equipment. Nuclear medicine equipment, such as PET/CT and SPECT/CT scanners, requires significant investment, which can be a barrier for many healthcare facilities, especially those in developing regions or smaller medical centers.

The initial purchase cost, along with maintenance, installation, and operational costs, can be prohibitive for many institutions, limiting the accessibility of advanced diagnostic tools. This high cost can also lead to slower adoption rates, particularly in regions with limited healthcare budgets or inadequate reimbursement systems.

As a result, there is an ongoing need for more cost-effective solutions and financial models that can make nuclear medicine technologies more accessible to a broader range of healthcare providers.

The global nuclear medicine equipment market is highly competitive, with major players such as Siemens Healthineers, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems, Mediso Medical Imaging Systems, Digirad Corporation, SurgicEye GmbH, DDD-Diagnostic A/S, and Neusoft Medical Systems Co., Ltd. leading the way. These companies are at the forefront of innovation, constantly developing new technologies and enhancing existing products to meet the growing demand for advanced nuclear medicine solutions.

Siemens Healthineers and GE Healthcare dominate the market with their extensive portfolios of imaging systems, including hybrid PET/CT and SPECT/CT scanners, which are essential for accurate diagnostic imaging. Philips Healthcare and Canon Medical Systems also contribute significantly with their high-quality imaging devices that provide enhanced resolution and greater diagnostic precision. Smaller players like Mediso and Digirad focus on niche markets, offering specialized products such as solid-state gamma cameras and compact imaging systems, catering to the growing need for more versatile and affordable solutions.

These companies are also investing heavily in research and development to incorporate the latest advancements, including artificial intelligence, machine learning, and improved radiopharmaceuticals, into their products. Strategic partnerships, acquisitions, and regional expansions are also crucial to maintaining a competitive edge in this rapidly evolving market. As healthcare systems worldwide increasingly adopt nuclear medicine technologies for disease detection and treatment, these market leaders continue to shape the future of the industry.

Nuclear Medicine Equipment Market Segmentation:

Segmentation 1: by Application

  • Cardiology
  • Oncology
  • Neurology
  • Other Applications

Segmentation 2: by End User

  • Hospitals
  • Imaging Centres
  • Academic and Research Centres
  • Other End Users

Segmentation 3: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest-of-the-World

One of the most significant emerging trends in the global nuclear medicine equipment market is the integration of artificial intelligence (AI) and machine learning (ML) into imaging systems. These technologies are revolutionizing the field by enhancing diagnostic accuracy, optimizing workflows, and enabling personalized treatment planning.

AI and ML algorithms are increasingly utilized to analyse complex imaging data from PET/CT and SPECT/CT scans, allowing for more precise detection of abnormalities such as tumours, cardiovascular issues, and neurological disorders. By automating image interpretation and quantifying radiotracer uptake, these technologies assist clinicians in making faster and more accurate diagnoses. Moreover, AI-driven tools facilitate the development of personalized treatment strategies by correlating imaging findings with patient-specific data, leading to tailored therapeutic approaches.

This trend is supported by advancements in hybrid imaging technologies, which combine functional and anatomical imaging modalities, providing comprehensive insights into disease processes. The growing adoption of AI and ML in nuclear medicine is expected to continue, driven by the demand for more efficient, accurate, and personalized healthcare solutions.

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

1. Global Nuclear Medicine Equipment Market: Industry Outlook

  • 1.1 Introduction
  • 1.2 Market Trends
  • 1.3 Regulatory Framework
  • 1.4 Patent Analysis
  • 1.5 Case Studies
  • 1.6 Product Benchmarking
  • 1.7 Market Dynamics
    • 1.7.1 Impact Analysis
    • 1.7.2 Market Drivers
    • 1.7.3 Market Challenges
    • 1.7.4 Market Opportunities

2. Global Nuclear Medicine Equipment Market (by Application), ($Billion), 2024-2035

  • 2.1 Cardiology
  • 2.2 Oncology
  • 2.3 Neurology
  • 2.4 Other Applications

3. Global Nuclear Medicine Equipment Market (by End User), ($Billion), 2024-2035

  • 3.1 Hospitals
  • 3.2 Imaging Centres
  • 3.3 Academic and Research Centres
  • 3.4 Other End Users

4. Global Nuclear Medicine Equipment Market (Region), ($Billion), 2023-2035

  • 4.1 North America
    • 4.1.1 Key Findings
    • 4.1.2 Market Dynamics
    • 4.1.3 Market Sizing and Forecast
      • 4.1.3.1 North America Nuclear Medicine Equipment Market, by Country
        • 4.1.3.1.1 U.S.
        • 4.1.3.1.2 Canada
  • 4.2 Europe
    • 4.2.1 Key Findings
    • 4.2.2 Market Dynamics
    • 4.2.3 Market Sizing and Forecast
      • 4.2.3.1 Europe Nuclear Medicine Equipment Market, by Country
        • 4.2.3.1.1 Germany
        • 4.2.3.1.2 U.K.
        • 4.2.3.1.3 France
        • 4.2.3.1.4 Italy
        • 4.2.3.1.5 Spain
        • 4.2.3.1.6 Rest of the Europe
  • 4.3 Asia Pacific
    • 4.3.1 Key Findings
    • 4.3.2 Market Dynamics
    • 4.3.3 Market Sizing and Forecast
      • 4.3.3.1 Asia Pacific Nuclear Medicine Equipment Market, by Country
        • 4.3.3.1.1 China
        • 4.3.3.1.2 Japan
        • 4.3.3.1.3 India
        • 4.3.3.1.4 Australia
        • 4.3.3.1.5 Rest of Asia Pacific
  • 4.4 Rest of the World
    • 4.4.1 Key Findings
    • 4.4.2 Market Dynamics
    • 4.4.3 Market Sizing and Forecast

5. Global Nuclear Medicine Equipment Market: Competitive Landscape and Company Profiles

  • 5.1 Key Strategies and Development
    • 5.1.1 Mergers and Acquisitions
    • 5.1.2 Synergistic Activities
    • 5.1.3 Business Expansions and Funding
    • 5.1.4 Product Launches and Approvals
    • 5.1.5 Other Activities
  • 5.2 Company Profiles
    • 5.2.1 Koninklijke Philips N.V.
      • 5.2.1.1 Overview
      • 5.2.1.2 Top Products / Product Portfolio
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Target Customers/End-Users
      • 5.2.1.5 Key Personnel
      • 5.2.1.6 Analyst View
    • 5.2.2 Siemens Healthineers AG
      • 5.2.2.1 Overview
      • 5.2.2.2 Top Products / Product Portfolio
      • 5.2.2.3 Top Competitors
      • 5.2.2.4 Target Customers/End-Users
      • 5.2.2.5 Key Personnel
      • 5.2.2.6 Analyst View
    • 5.2.3 GE Healthcare
      • 5.2.3.1 Overview
      • 5.2.3.2 Top Products / Product Portfolio
      • 5.2.3.3 Top Competitors
      • 5.2.3.4 Target Customers/End-Users
      • 5.2.3.5 Key Personnel
      • 5.2.3.6 Analyst View
    • 5.2.4 Digirad Corporation
      • 5.2.4.1 Overview
      • 5.2.4.2 Top Products / Product Portfolio
      • 5.2.4.3 Top Competitors
      • 5.2.4.4 Target Customers/End-Users
      • 5.2.4.5 Key Personnel
      • 5.2.4.6 Analyst View
    • 5.2.5 Mediso Medical Imaging Systems Ltd.
      • 5.2.5.1 Overview
      • 5.2.5.2 Top Products / Product Portfolio
      • 5.2.5.3 Top Competitors
      • 5.2.5.4 Target Customers/End-Users
      • 5.2.5.5 Key Personnel
      • 5.2.5.6 Analyst View
    • 5.2.6 SurgicEye GmbH
      • 5.2.6.1 Overview
      • 5.2.6.2 Top Products / Product Portfolio
      • 5.2.6.3 Top Competitors
      • 5.2.6.4 Target Customers/End-Users
      • 5.2.6.5 Key Personnel
      • 5.2.6.6 Analyst View
    • 5.2.7 Canon Medical Systems Corporation
      • 5.2.7.1 Overview
      • 5.2.7.2 Top Products / Product Portfolio
      • 5.2.7.3 Top Competitors
      • 5.2.7.4 Target Customers/End-Users
      • 5.2.7.5 Key Personnel
      • 5.2.7.6 Analyst View
    • 5.2.8 DDD-Diagnostic A/S
      • 5.2.8.1 Overview
      • 5.2.8.2 Top Products / Product Portfolio
      • 5.2.8.3 Top Competitors
      • 5.2.8.4 Target Customers/End-Users
      • 5.2.8.5 Key Personnel
      • 5.2.8.6 Analyst View
    • 5.2.9 Neusoft Medical Systems Co., Ltd.
      • 5.2.9.1 Overview
      • 5.2.9.2 Top Products / Product Portfolio
      • 5.2.9.3 Top Competitors
      • 5.2.9.4 Target Customers/End-Users
      • 5.2.9.5 Key Personnel
      • 5.2.9.6 Analyst View
    • 5.2.10 CMR Naviscan Corporation
      • 5.2.10.1 Overview
      • 5.2.10.2 Top Products / Product Portfolio
      • 5.2.10.3 Top Competitors
      • 5.2.10.4 Target Customers/End-Users
      • 5.2.10.5 Key Personnel
      • 5.2.10.6 Analyst View

6. Research Methodology

List of Figures

  • Figure: Global Nuclear Medicine Equipment Market (by Application), $Billion, 2024 and 2035
  • Figure: Global Nuclear Medicine Equipment Market (by End User), $Billion, 2024 and 2035
  • Figure: Global Nuclear Medicine Equipment Market (by Region), $Billion, 2024 and 2035
  • Figure: Global Nuclear Medicine Equipment Market Key Trends, Analysis

List of Tables

  • Table: Global Nuclear Medicine Equipment Market Dynamics, Impact Analysis
  • Table: Global Nuclear Medicine Equipment Market (by Region), $Billion, 2024-2035